AAMC Home   Tomorrow's Doctors Tomorrow's Cures
  Home  Government Affairs   Newsroom   Meetings   Publications Shopping Cart   Site Map    

Home

Washington Highlights

Testimony & Correspondence

Top Issues:

 

Education

 

GME & IME Payments

HIPAA

Labor-HHS Appropriations

Research

Teaching Hospitals

Teaching Physicians

Veterans Affairs

Workforce

Government Affairs & Advocacy Site Map

Contact

 

Government Affairs Home > Washington Highlights > April 12, 2002

AAMC Issues New Policy Statement on Cloning

April 12, 2002 - The AAMC April 10 issued a new policy statement on cloning. The statement restates the Association's strong opposition to human reproductive cloning, stating that, "To expose any person to the known risks and uncertainties involved in reproductive cloning would be unethical and unconscionable."

The statement stresses that "it is important to recognize the difference between reproductive cloning and the use of cloning technology that does not create a human being." The AAMC statement urges Congress "to oppose legislation that would prohibit research on the use of nuclear transplantation to produce stem cells. Such a blanket prohibition would have grave implications for future advances in medical research and human healing. Since other nations have already decided not to enact such law, a Congressional ban would also pose a serious threat to the continued world leadership of the United States in medical research and biotechnology."

The AAMC statement concludes that, "The current opportunities in medical research are unparalleled in our nation's history, and among the brightest of these is the further study and application of both adult and embryonic stem cell technology. The production of stem cells by nuclear transplantation may yet prove the most powerful and widely beneficial of all. However, we will never see the fulfillment of any of this promise if we choose to take the perilous and unprecedented path of banning through legislation research on nuclear transplantation to produce stem cells."

Information:

Tony Mazzaschi, Senior Associate Vice President
AAMC Biomedical Health Sciences Research
tmazzaschi@aamc.org
(202) 828-0059

Dave Moore, Senior Associate Vice President
AAMC Government Relations
dbmoore@aamc.org
(202) 828-0525

e-mail icon Get Washington Highlights in your Inbox!

Contact Us    © 1995-2008 AAMC    Terms and Conditions    Privacy Statement